Keyphrases
5-Aminolevulinic Acid (5-ALA)
21%
Actinic Keratosis
71%
Basal Cell Carcinoma
25%
Capecitabine
38%
Cell Surface
22%
Chemokine Ligand 12 (CXCL12)
19%
Cosmetic Outcome
31%
Dermatoscopy
23%
Diagnostic Accuracy
27%
Exotoxin A
27%
Hyaluronan
25%
Illness
21%
Imiquimod
34%
Imiquimod 5% Cream
38%
Immunostaining
38%
Incidence Rate
21%
Lentigo Maligna
46%
Lentigo Maligna Melanoma
42%
Lip Defect
19%
Malignant Melanoma
32%
Management Plan
19%
Matrix metalloproteinase-1 (MMP-1)
19%
Melanoma
64%
Methyl Aminolevulinate
22%
Microcystic Adnexal Carcinoma
19%
Mohs Micrographic Surgery
57%
Non-melanoma Skin Cancer
60%
Nucleotide Sequence
19%
Ovine
19%
Parkinson's Disease
19%
Photodynamic Therapy
76%
Pigmented Neoplasm
21%
Plaque Type
19%
Polarized Light
19%
Pulsed Dye Laser
23%
Response-outcome
19%
Skin Cancer
50%
Solid Organ Transplant Recipients
59%
Squamous Cell Carcinoma (SqCC)
53%
Staphylococcus Aureus
21%
Streptococcal Pyrogenic Exotoxin
52%
Syringoma
19%
Teledermatology
38%
Toxic Shock Syndrome
30%
Toxic Shock Syndrome toxin-1 (TSST-1)
57%
Tumor
33%
United States
47%
University of Minnesota
40%
Vehicle Control
21%
Wide Local Excision
19%
Medicine and Dentistry
Abdominal Tumor
19%
Acivicin
19%
Aminolevulinic Acid
21%
Aminolevulinic Acid Methyl Ester
21%
Carbon Dioxide
19%
Carboxymethyl Cellulose
19%
Carcinogenesis
19%
Cosmetic
19%
Cosmetics
36%
Dermatofibroma
19%
Dermatology
21%
Dermatoscopy
22%
Diagnostic Accuracy
27%
Diseases
26%
Erbium
19%
Erythema
19%
Exotoxin
38%
Facial Skin
19%
Hyaluronate Synthetase
19%
Immunohistochemistry
41%
Lentigo
19%
Lentigo Maligna
50%
Matrilysin
19%
Melanoma
100%
Microcystic Adnexal Carcinoma
19%
Mitogenicity
19%
Mohs Surgery
57%
Neck
19%
Neoplasm
92%
Non Melanoma Skin Cancer
38%
Parathyroid Cancer
19%
Parkinson's Disease
19%
Pedicle
19%
Photochemotherapy
57%
Photograph
19%
Polyglactin
19%
Postinflammatory Hyperpigmentation
19%
Precursor
19%
Q-Switched Ruby Laser
19%
Receptor
19%
Recurrent Disease
26%
Restylane
26%
Skin Cancer
19%
Skin Surgery
19%
Syringoma
19%
T Cell
19%
Teledermatology
38%
Toxic Shock Syndrome
19%
Verteporfin
19%
Wide Local Excision
19%
Pharmacology, Toxicology and Pharmaceutical Science
Actinic Keratosis
64%
Aminolevulinic Acid
24%
Aminolevulinic Acid Methyl Ester
21%
Basal Cell Carcinoma
19%
Bowen's Disease
6%
Capecitabine
38%
Contact Dermatitis
12%
Diseases
26%
Distant Metastasis
5%
Exotoxin
28%
Hyaluronate Synthetase
19%
Hyaluronic Acid
7%
Hypotension
5%
Imiquimod
38%
Isoprenaline
8%
Leporidae
38%
Matrigel
9%
Matrilysin
19%
Matrix Metalloproteinase
9%
Melanoma
24%
Mortality Rate
5%
Neoplasm
11%
Nodular Basal Cell Carcinoma
5%
Non Melanoma Skin Cancer
33%
Overall Survival
8%
Parathyroid Cancer
19%
Parkinson's Disease
19%
Photodynamic Therapy
57%
Polymyxin B
6%
Scarlet Fever
9%
Septic Shock
9%
Side Effect
15%
Skin Allergy
6%
Skin Cancer
40%
Skin Carcinoma
19%
Squamous Cell Carcinoma
55%
Streptococcus Group A
9%
Survival Rate
10%
Syndrome
12%
Toxic Shock Syndrome
28%
Toxic Shock Syndrome Toxin
19%
Toxic Shock Syndrome Toxin 1
28%
Toxicodendron
19%